({[(2R)-2,3-bis[(15-methylhexadecanoyl)oxy]propoxy](hydroxy)phosphoryl}oxy)({[(2R,3R,5R)-3,4-dihydroxy-5-(2-hydroxy-4-imino-1,4-dihydropyrimidin-1-yl)oxolan-2-yl]methoxy})phosphinic acid

Term ID

CHEBI:185170

Synonyms

[(2R)-3-[[[(2R,3R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-(15-methylhexadecanoyloxy)propyl] 15-methylhexadecanoate

Definition

References

Chemspider:74877965
HMDB:HMDB0116252

Ontology

ChEBI ( EBI )

Relationships

is a type of: CDP-diacylglycerol

CDP-diacylglycerol Show first 5 Terms

Phenotype

Phenotype resulting from ({[(2R)-2,3-bis[(15-methylhexadecanoyl)oxy]propoxy](hydroxy)phosphoryl}oxy)({[(2R,3R,5R)-3,4-dihydroxy-5-(2-hydroxy-4-imino-1,4-dihydropyrimidin-1-yl)oxolan-2-yl]methoxy})phosphinic acid

Phenotype where environments contain ({[(2R)-2,3-bis[(15-methylhexadecanoyl)oxy]propoxy](hydroxy)phosphoryl}oxy)({[(2R,3R,5R)-3,4-dihydroxy-5-(2-hydroxy-4-imino-1,4-dihydropyrimidin-1-yl)oxolan-2-yl]methoxy})phosphinic acid

Phenotype modified by environments containing ({[(2R)-2,3-bis[(15-methylhexadecanoyl)oxy]propoxy](hydroxy)phosphoryl}oxy)({[(2R,3R,5R)-3,4-dihydroxy-5-(2-hydroxy-4-imino-1,4-dihydropyrimidin-1-yl)oxolan-2-yl]methoxy})phosphinic acid

Human Disease Model